EU Science Hub

Science updates

Almost 300 non-animal models can be used for research on respiratory diseases and the development of new drugs and therapies
Sep 18 2020

A new JRC study describes almost 300 non-animal models used for research on respiratory diseases and the development of new drugs and therapies. 

Respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and lung cancer are the most common of all diseases and causes of death worldwide.

The JRC database includes 211 new chemicals with negative results in the Ames test
Jul 31 2020

The database now includes 211 new chemicals with negative results in the Ames test, a widely employed in vitro method based on bacteria to identify if a chemical can cause mutations in DNA.

Damage to DNA caused by chemicals is concerning since it can contribute to the initiation and development of many serious health effects including birth defects and cancer.

AR-CALUX® in vitro method
AR-CALUX® in vitro method validated by the JRC included in an OECD test guideline
Jul 09 2020

The AR-CALUX® method was validated by the JRC’s EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) and has now been taken up in an international test guideline by the Organisation of Economic Cooperation and Development (OECD) for the detection of androgen-like chemicals.

Gauging the output and impact of biomedical research
Gauging the output and impact of biomedical research
Jun 24 2020

The JRC has published initial results of a survey it conducted to gather the views of EU-funded researchers on how their work has contributed to scientific innovation and benefitted society

Studying the effects of chemical mixtures on the developing brain – with cells and maths
Studying the effects of chemical mixtures on the developing brain – with cells and maths
Jun 08 2020

A JRC study shows that the effects of chemical mixtures on the developing brain can be assessed using human cells in vitro combined with mathematical modelling

EURL ECVAM Recommendation on non-aniaml derived antibodies
Better antibodies without using animals
May 15 2020

The JRC’s EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) has issued a Recommendation urging end-users and other stakeholders to recognise the scientific validity of non-animal-derived antibodies and to stop using animals for antibody development and production.

Regulating endocrine disrupting chemicals – what do citizens and stakeholders think?
Regulating endocrine disrupting chemicals – what do citizens and stakeholders think?
Apr 15 2020

The JRC has compiled the results of three recent surveys aimed at gaining the views and experiences of citizens, stakeholders and companies related to endocrine disruptors.

The surveys probed concerns about the potential health and environmental effects of endocrine disrupting chemicals, solicited views on the ways in which these chemicals are assessed and regulated within the EU, and explored the social and economic consequences of regulatory action.

EURL ECVAM Status Report 2019
EURL ECVAM Status Report 2019
Mar 10 2020

The JRC’s EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) has just published its Status Report 2019 on the development, validation and regulatory acceptance of alternative methods used for scientific purposes.

JRC launches online survey on innovation and impact of biomedical research
JRC launches online survey on innovation and impact of biomedical research
Feb 24 2020

The JRC has launched an online survey to gather feedback from researchers who received financial support from projects funded under FP5, FP6, FP7, or H2020 framework programmes.

It is part of a bigger initiative to gain a better understanding of the outputs and impacts of biomedical research.
 
It targets researchers who have participated in EU funded projects during the past 20 years in the fields of breast cancer, prostate cancer or Alzheimer’s disease and other dementias.

JRC takes up editorial leadership of journal for reproductive toxicology
JRC takes up editorial leadership of journal for reproductive toxicology
Feb 11 2020

Effective from January 2020, JRC scientist Anna Price has been appointed Editor-in-Chief of the Elsevier journal Reproductive Toxicology.

The prestigious appointment is recognition of Anna’s work at the JRC and its EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) and the significant contributions made in fields including developmental toxicology, both in terms of basic research and improving chemical hazard assessment using alternative (non-animal) methods.

Pages